Send me a link:

*Text messaging rates may apply.

 Dow Down 1.73% Nasdaq Down 2.00%

Amicus Therapeutics, Inc. (FOLD)

-NasdaqGM
4.20 Down 0.28(6.25%) 3:15PM EDT - Nasdaq Real Time Price
Prev Close:4.48
Open:4.40
Bid:4.21 x 5000
Ask:4.22 x 500
1y Target Est:6.00
Beta:1.82
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:4.20 - 4.40
52wk Range:1.77 - 4.74
Volume:612,783
Avg Vol (3m):1,533,340
Market Cap:270.23M
P/E (ttm):N/A
EPS (ttm):-1.06
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
FOLDDown 6.25%270.23M
SHPGDown 1.73%48.26B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):351.95
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.93
Quarterly EPS Est (Jun-14) :-0.23
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for various rare and orphan diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback